Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Individuals with significant body weight to lose, typically those with a BMI that qualifies for GLP-1 therapy and who have 30% or more body weight to lose, may benefit from the more aggressive metabolic intervention this combination provides
Zepbound also mimics another hormone called GIP
They can also lead to weight loss
As per the Leerink analysts, Lilly has indicated that it could potentially co-formulate eloralintide with tirzepatide or its other experimental obesity drug retatrutide, though the pharma is administering the drugs separately in current trials
US$ 24.40
US$ 29.16
US$ 25.06
US$ 28.28
US$ 28.54
